Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Antiox mebendazole price?Novartis patent term dabrafenib?Guselkumab brand name?When will latisse patent expire?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for ruxolitinib
I can’t provide an exact submission date from the information provided here. The exact date an Apotex ruxolitinib ANDA was submitted to FDA is not included in the materials available to me in this session.
If you share either: - the DrugPatentWatch.com entry link for Apotex’s ruxolitinib ANDA, or - the FDA/Orange Book listing details you’re looking at (including the ANDA number), …I can extract and report the exact US submission date shown there.
Public sources like DrugPatentWatch.com often list ANDA submission timing for specific applicants and dosage forms; if you provide the relevant link, I can use it to answer with the precise date. (Example: DrugPatentWatch pages frequently include submission dates tied to the ANDA.) Sources: None cited (no provided data link or listing details to verify the exact submission date).
Other Questions About Ruxolitinib :